Integrated Solutions and Strategies for the Discovery of Targeted Protein Degraders

DATE
July 25, 2024
TIME
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST - Duration: 60 Minutes

Overview

The Targeted Protein Degradation (TPD) approach has enabled a switch to event-driven pharmacology, providing a revolutionary new strategy to target proteins previously considered undruggable. Since 2016, WuXi AppTec has been diligently building an integrated research platform encompassing target discovery and validation, hit finding, lead optimization, and IND enabling studies to support accelerated drug discovery for this exciting new modality.


Key Learning Objectives:
  • Integrated solutions for the discovery of targeted protein degraders
  • Selection strategies for diversified in vitro assays
  • Drug-resistant in vivo models to support target protein degradation research
Who Should Attend:
  • Researchers working on targeted protein degraders
  • Researchers working on undruggable targets
  • Scientists seeking new solutions and strategies for the discovery of targeted protein degraders

Brought to you by:
WuXi AppTec

Speakers

Lingbing Sun
Senior Director of TPD Discovery,
WuXi AppTec
Jian Xiang,
Director of In Vivo Pharmacology,
WuXi AppTec
Melissa O'Meara
Forensic Science Consultant,
C&EN Media Group

Registration

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2024 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy